Construct: ORF ccsbBroadEn_06211
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF014122.1_s300c1, BRDN0000456759
- DNA Barcode:
- None
- Epitope Tag:
- None
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- FGFR2 (2263)
Vector Information:
- Vector Backbone:
- pDONR223
- Pol II Cassette 1:
- n/a
- Pol II Cassette 2:
- n/a
- Selection Marker:
- n/a
- Visible Reporter:
- n/a
- Epitope Tag:
- n/a
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144918.2 | 99.9% | 100% | 351A>G |
| 2 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144916.1 | 99.6% | 99.7% | 351A>G;937_942delGTAACA |
| 3 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015924.2 | 97% | 97.1% | 1_57del;408A>G;994_999delGTAACA |
| 4 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_023029.2 | 96.1% | 96% | 110_187del;429A>G;1015_1020delGTAACA |
| 5 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447889.1 | 93.9% | 93.8% | 1_57del;167_244del;486A>G |
| 6 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447887.1 | 93.6% | 93.6% | (many diffs) |
| 7 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447891.1 | 93.4% | 93.4% | (many diffs) |
| 8 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015925.2 | 92.3% | 92.2% | (many diffs) |
| 9 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144915.1 | 90.6% | 89.3% | (many diffs) |
| 10 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447888.1 | 90.4% | 90.2% | (many diffs) |
| 11 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447890.1 | 90.2% | 90% | (many diffs) |
| 12 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001320658.2 | 85.9% | 85.8% | 110_454del;696A>G |
| 13 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_000141.4 | 85.7% | 85.6% | 110_454del;696A>G;1282_1287delGTAACA |
| 14 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144919.2 | 85.3% | 85% | (many diffs) |
| 15 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_022970.3 | 82.6% | 82.4% | (many diffs) |
| 16 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001320654.1 | 82.5% | 80.2% | (many diffs) |
| 17 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_006717708.3 | 80.9% | 80.7% | (many diffs) |
| 18 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015921.2 | 79.6% | 79.4% | (many diffs) |
| 19 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_017015920.2 | 76.7% | 76.3% | (many diffs) |
| 20 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_006717710.4 | 76.5% | 76.1% | (many diffs) |
| 21 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144913.1 | 76.2% | 75.8% | (many diffs) |
| 22 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144914.1 | 72% | 71.9% | (many diffs) |
| 23 | human | 2263 | FGFR2 | fibroblast growth factor re... | NM_001144917.2 | 71.9% | 71.9% | 110_454del;696A>G;937_938ins342 |
| 24 | human | 2263 | FGFR2 | fibroblast growth factor re... | XM_024447892.1 | 60.7% | 60.7% | 0_1ins825;112_117delGTAACA |
| 25 | human | 2263 | FGFR2 | fibroblast growth factor re... | NR_073009.2 | 47.6% | (many diffs) | |
| 26 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | NM_001347638.1 | 89.3% | 96.2% | (many diffs) |
| 27 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507357.3 | 89.1% | 96% | (many diffs) |
| 28 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241675.2 | 86% | 92.5% | (many diffs) |
| 29 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241677.2 | 85.8% | 92.5% | (many diffs) |
| 30 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | NM_201601.2 | 85.6% | 92.3% | (many diffs) |
| 31 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241676.2 | 82.8% | 89.2% | (many diffs) |
| 32 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507354.3 | 82.6% | 88.9% | (many diffs) |
| 33 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241674.2 | 77% | 82.9% | (many diffs) |
| 34 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | NM_010207.2 | 76.9% | 82.7% | (many diffs) |
| 35 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507350.3 | 74.1% | 79.7% | (many diffs) |
| 36 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507349.2 | 74% | 79.5% | (many diffs) |
| 37 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_011241673.2 | 74% | 79.5% | (many diffs) |
| 38 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_017321975.1 | 74% | 79.5% | (many diffs) |
| 39 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_017321977.1 | 73.3% | 78.6% | (many diffs) |
| 40 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_017321976.1 | 70.4% | 75.5% | (many diffs) |
| 41 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XM_006507352.2 | 70.2% | 75.3% | (many diffs) |
| 42 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XR_001785477.1 | 29% | (many diffs) | |
| 43 | mouse | 14183 | Fgfr2 | fibroblast growth factor re... | XR_001785478.1 | 28.7% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 69
- ORF end:
- 2181
- ORF length:
- 2112
- Sequence:
-
1 gttcgttgca acaaattgat gagcaatgct tttttataat gccaacttTG TACAAAAAAG 61 TTGGCACCAT GGTCAGCTGG GGTCGTTTCA TCTGCCTGGT CGTGGTCACC ATGGCAACCT 121 TGTCCCTGGC CCGGCCCTCC TTCAGTTTAG TTGAGGATAC CACATTAGAG CCAGAAGGAG 181 CACCATACTG GACCAACACA GAAAAGATGG AAAAGCGGCT CCATGCTGTG CCTGCGGCCA 241 ACACTGTCAA GTTTCGCTGC CCAGCCGGGG GGAACCCAAT GCCAACCATG CGGTGGCTGA 301 AAAACGGGAA GGAGTTTAAG CAGGAGCATC GCATTGGAGG CTACAAGGTA CGAAACCAGC 361 ACTGGAGCCT CATTATGGAA AGTGTGGTCC CATCTGACAA GGGAAATTAT ACCTGTGTGG 421 TGGAGAATGA ATACGGGTCC ATCAATCACA CGTACCACCT GGATGTTGTG GAGCGATCGC 481 CTCACCGGCC CATCCTCCAA GCCGGACTGC CGGCAAATGC CTCCACAGTG GTCGGAGGAG 541 ACGTAGAGTT TGTCTGCAAG GTTTACAGTG ATGCCCAGCC CCACATCCAG TGGATCAAGC 601 ACGTGGAAAA GAACGGCAGT AAATACGGGC CCGACGGGCT GCCCTACCTC AAGGTTCTCA 661 AGGCCGCCGG TGTTAACACC ACGGACAAAG AGATTGAGGT TCTCTATATT CGGAATGTAA 721 CTTTTGAGGA CGCTGGGGAA TATACGTGCT TGGCGGGTAA TTCTATTGGG ATATCCTTTC 781 ACTCTGCATG GTTGACAGTT CTGCCAGCGC CTGGAAGAGA AAAGGAGATT ACAGCTTCCC 841 CAGACTACCT GGAGATAGCC ATTTACTGCA TAGGGGTCTT CTTAATCGCC TGTATGGTGG 901 TAACAGTCAT CCTGTGCCGA ATGAAGAACA CGACCAAGAA GCCAGACTTC AGCAGCCAGC 961 CGGCTGTGCA CAAGCTGACC AAACGTATCC CCCTGCGGAG ACAGGTTTCG GCTGAGTCCA 1021 GCTCCTCCAT GAACTCCAAC ACCCCGCTGG TGAGGATAAC AACACGCCTC TCTTCAACGG 1081 CAGACACCCC CATGCTGGCA GGGGTCTCCG AGTATGAACT TCCAGAGGAC CCAAAATGGG 1141 AGTTTCCAAG AGATAAGCTG ACACTGGGCA AGCCCCTGGG AGAAGGTTGC TTTGGGCAAG 1201 TGGTCATGGC GGAAGCAGTG GGAATTGACA AAGACAAGCC CAAGGAGGCG GTCACCGTGG 1261 CCGTGAAGAT GTTGAAAGAT GATGCCACAG AGAAAGACCT TTCTGATCTG GTGTCAGAGA 1321 TGGAGATGAT GAAGATGATT GGGAAACACA AGAATATCAT AAATCTTCTT GGAGCCTGCA 1381 CACAGGATGG GCCTCTCTAT GTCATAGTTG AGTATGCCTC TAAAGGCAAC CTCCGAGAAT 1441 ACCTCCGAGC CCGGAGGCCA CCCGGGATGG AGTACTCCTA TGACATTAAC CGTGTTCCTG 1501 AGGAGCAGAT GACCTTCAAG GACTTGGTGT CATGCACCTA CCAGCTGGCC AGAGGCATGG 1561 AGTACTTGGC TTCCCAAAAA TGTATTCATC GAGATTTAGC AGCCAGAAAT GTTTTGGTAA 1621 CAGAAAACAA TGTGATGAAA ATAGCAGACT TTGGACTCGC CAGAGATATC AACAATATAG 1681 ACTATTACAA AAAGACCACC AATGGGCGGC TTCCAGTCAA GTGGATGGCT CCAGAAGCCC 1741 TGTTTGATAG AGTATACACT CATCAGAGTG ATGTCTGGTC CTTCGGGGTG TTAATGTGGG 1801 AGATCTTCAC TTTAGGGGGC TCGCCCTACC CAGGGATTCC CGTGGAGGAA CTTTTTAAGC 1861 TGCTGAAGGA AGGACACAGA ATGGATAAGC CAGCCAACTG CACCAACGAA CTGTACATGA 1921 TGATGAGGGA CTGTTGGCAT GCAGTGCCCT CCCAGAGACC AACGTTCAAG CAGTTGGTAG 1981 AAGACTTGGA TCGAATTCTC ACTCTCACAA CCAATGAGGA ATACTTGGAC CTCAGCCAAC 2041 CTCTCGAACA GTATTCACCT AGTTACCCTG ACACAAGAAG TTCTTGTTCT TCAGGAGATG 2101 ATTCTGTTTT TTCTCCAGAC CCCATGCCTT ACGAACCATG CCTTCCTCAG TATCCACACA 2161 TAAACGGCAG TGTTAAAACA TTGCCAACTT TCTTGTACAA AGTTGGcatt ataagaaagc 2221 attgcttatc aatttgttgc aacgaac